News

Fierce Biotech names Mestag Therapeutics as one of its “Fierce 15” Biotech Companies of 2021

Read More

Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures

Read More

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Read More

Mestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer

Read More

Mestag Therapeutics congratulates Founder Professor David A. Tuveson upon his appointment as 2021 President of The American Association for Cancer Research

Read More